Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Searchlight Pharma is a leading Canadian specialty healthcare company focused on the acquisition, commercialization, and focused development of innovative pharmaceutical products. The company maintains a diverse portfolio of over 60 brands across key therapeutic areas including women's health, dermatology, allergy, and pain management. Notable products include the Estetrol-based contraceptive Nextstellis and the menopause hormone therapy Donesta, as well as dermatology treatments Twyneo and Epsolay. In April 2024, Searchlight Pharma was acquired by Apotex, where it now operates as a specialized division within the global health company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Search Capital.